PHI with Ulcerative ileocolitis
How does this condition affect your private health insurance?
Ileocolitis ulcerosa is a form of inflammatory bowel disease (IBD) characterized by chronic inflammation and ulceration affecting the inner lining of both the ileum (the final part of the small intestine) and the colon (large intestine). It's an autoimmune condition where the body's immune system mistakenly attacks its own digestive tract. Symptoms include persistent diarrhea, often mixed with blood and mucus, abdominal pain, urgency, tenesmus, weight loss, and fatigue. The inflammation can range from mild to severe, leading to significant impairment of quality of life during flare-ups. Complications can include anemia, strictures, toxic megacolon, and an increased risk of colorectal cancer over time. Management aims to induce and maintain remission.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 60%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for an acute flare-up
Duration of Illness (Lifetime)
Chronic, lifelong condition with periods of remission and relapse
Cost of Treatment (Initial)
Moderately high, involving diagnostics, medications, and potentially hospitalization; ranges from thousands to tens of thousands of dollars depending on severity and region
Cost of Treatment (Lifetime)
Very high, due to long-term medication (e.g., biologics), regular monitoring, potential surgeries (colectomy), and management of complications; easily exceeds hundreds of thousands of dollars
Mortality Rate
Low directly from the disease itself, but complications like toxic megacolon, severe hemorrhage, or surgical complications can increase mortality risk, approximately 1-5% in severe cases over a lifetime
Risk of Secondary Damages
High, including anemia, malnutrition, arthritis, skin lesions (e.g., erythema nodosum, pyoderma gangrenosum), eye inflammation (uveitis, episcleritis), primary sclerosing cholangitis, and significantly increased risk of colorectal cancer (10-30% over 20 years)
Probability of Full Recovery
Extremely low for a complete, permanent recovery without any medical intervention or future relapses; management aims for sustained remission
Underlying Disease Risk
High probability of extra-intestinal manifestations (e.g., arthritis, uveitis, primary sclerosing cholangitis) and comorbidities like anemia and osteoporosis; not typically 'underlying diseases' causing UC, but rather associated conditions